Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Mar 2020
Historique:
received: 17 08 2019
revised: 29 10 2019
accepted: 02 11 2019
entrez: 2 1 2020
pubmed: 2 1 2020
medline: 9 6 2020
Statut: ppublish

Résumé

Monitoring pharmacological active compounds in pharmaceutical preparations of medical cannabis and in conventional and non-conventional biological matrices of treated individuals use requires both a wide linear range and sensitive detection. We have developed and validated a fast and sensitive method using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) for analysis of Δ-9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors Δ-9-tetrahydrocannabinolic acid A (THCA-A) and cannabidiolic acid (CBDA) and some major metabolites of THC such as 11-nor-9-carboxy-THC (THC-COOH), 11-hydroxy-THC (11-OH-THC), Δ-9-THC-Glucuronide (THC-GLUC) and THC-COOH-Glucuronide (THC-COOH-GLUC) in conventional (whole blood and urine) and non-conventional (oral fluid and sweat) of individual treated with medical cannabis preparation. Specifically, THC, THCA-A, CBD and CBD-A were determined in cannabis decoction and oil prepared to treat individuals. The method used positive electrospray ionization (ESI) mode to reach the sensitivity needed to detect minimal amounts of analytes under investigations exposure with limits of quantification ranging from 0.2 to 0.5 ng per milliliter (ng/mL) or ng per patch in case of collected sweat. The validation results indicated this method was accurate (average inter/intra-day error, <10%), precise (inter/intra-day imprecision, <10%), and fast (10 min run time). In addition, time-consuming sample preparation was avoided applying dilute and shoot procedure, meeting the needs for potential large-scale population studies. The analysis of real samples demonstrated a pharmacokinetics of cannabinoids, their precursors and their metabolites dependent from quantity of carboxylated and decarboxylated compounds in pharmaceutical preparations.

Identifiants

pubmed: 31892011
pii: S0039-9140(19)31170-1
doi: 10.1016/j.talanta.2019.120537
pii:
doi:

Substances chimiques

Cannabinoids 0
Medical Marijuana 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

120537

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Simona Pichini (S)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy. Electronic address: simona.pichini@iss.it.

Giulio Mannocchi (G)

University of Camerino, Camerino, Italy.

Massimo Gottardi (M)

Comedical S.rL, Trento, Italy.

Ana Pilar Pérez-Acevedo (AP)

Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain.

Lourdes Poyatos (L)

Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain.

Esther Papaseit (E)

Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain.

Clara Pérez-Mañá (C)

Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain.

Magí Farré (M)

Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain.

Roberta Pacifici (R)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.

Francesco Paolo Busardò (FP)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH